Quarterly report pursuant to Section 13 or 15(d)

Licensing and Other Arrangements - NIAID (Details)

v3.21.2
Licensing and Other Arrangements - NIAID (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2008
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2017
Dec. 31, 2014
Oct. 31, 2011
Licensing and other arrangements                  
Revenue recognized   $ 550 $ 200 $ 1,094 $ 753        
Contingent liabilities   1,410   1,410   $ 1,410      
Arrangement with Governmental Agency | National Institute of Allergy and Infectious Diseases "NIAID" [Member]                  
Licensing and other arrangements                  
Contractual term 3 years                
Accounts receivable               $ 400  
Deferred revenue/Contract liabilities               $ 800  
Accounts receivable written off             $ 400    
Estimated refund liability           1,400      
Revenue recognized           (600)      
Contingent liabilities   $ 1,400   $ 1,400   $ 1,400      
Arrangement with Governmental Agency, Development One | National Institute of Allergy and Infectious Diseases "NIAID" [Member]                  
Licensing and other arrangements                  
Total contract amount awarded $ 64,800                
Arrangement with Governmental Agency, Development Two | National Institute of Allergy and Infectious Diseases "NIAID" [Member]                  
Licensing and other arrangements                  
Total contract amount awarded                 $ 28,000